Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Escalating Middle East tensions threaten global petroleum delivery

    July 22, 2026

    Global software teams adopt affordable open access AI systems

    July 22, 2026

    UK unemployment holds steady at 4.9 percent amid wage slowdown

    July 22, 2026
    Trending
    • Escalating Middle East tensions threaten global petroleum delivery
    • Global software teams adopt affordable open access AI systems
    • UK unemployment holds steady at 4.9 percent amid wage slowdown
    • Sardinia beach entry requires digital reservations and access fees
    • Russia sets legal framework for large AI models
    • Red heat alerts cover 17 Italian cities
    • Indonesia B50 biodiesel boosts domestic palm fuel use
    • Samsung holds top 10 rank with US$97.4 billion value
    Liverpool Daily PostLiverpool Daily Post
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Liverpool Daily PostLiverpool Daily Post
    Home » Australia reviews approval to grow genetically modified purple tomato
    Health

    Australia reviews approval to grow genetically modified purple tomato

    June 17, 2025
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    Australian regulators are reviewing a proposal to approve the cultivation and sale of a genetically modified purple tomato, potentially expanding the nation’s limited list of approved genetically modified (GM) crops. If successful, the tomato could be commercially available by next year, with initial production planned in greenhouses in south-east Queensland. Developed by UK-based scientists and commercialized by U.S. firm Norfolk Healthy Produce, the purple tomato has been engineered to contain genes from the snapdragon flower.

    These genes enable the tomato to produce anthocyanins, naturally occurring antioxidants also found in blueberries, blackberries, and eggplant skins. The resulting pigmentation gives the tomato its distinct purple hue. Dr. Nathan Pumplin, Chief Executive of Norfolk Healthy Produce, said the tomato offers enhanced nutritional properties without altering its essential nature. “It’s just a tomato,” he said, “what’s special is that it contains the same antioxidants found in other purple fruits.”

    The research behind the product originated at the John Innes Centre in the UK, led by Professor Cathie Martin. A co-founder of Norfolk Plant Sciences, Professor Martin is a recognized authority on the nutritional content of fruit and vegetables. Her research culminated in the development of the purple tomato after 18 years of work, earning her the prestigious Rank Prize for Nutrition. The tomato has already gained regulatory approval in the United States, where it has been sold for two years.

    In 2024 alone, over 100,000 punnets of the fruit and 13,000 seed packets were sold across the country. Following this success, the company is targeting international markets, including Australia and Canada. In Australia, All Aussie Farmers, a Victorian produce marketing company, has partnered with Norfolk to distribute the fruit domestically. Managing Director Travis Murphy said the product has generated strong interest from both retailers and chefs. Pending regulatory approval, initial rollout will be in Melbourne.

    Australia maintains strict oversight on GM crops, with only five currently approved: canola, cotton, safflower, bananas, and flowers. The Office of the Gene Technology Regulator (OGTR) is assessing the safety of the purple tomato for human health and environmental impact. A public consultation period will commence in September as part of the review process. In addition, Food Standards Australia New Zealand will conduct a safety assessment before the product is cleared for consumption. Experts such as Professor James Dale from Queensland University of Technology note that the approval process is rigorous, often requiring extensive documentation and trial data to ensure safety and compliance. – By MENA Newswire News Desk.

    Related Posts

    Belgian heatwave period records 1,747 excess deaths

    July 11, 2026

    France confirms Ebola patient discharged after recovery

    July 6, 2026

    EU adds €16.5m support for DRC Uganda Ebola response

    June 10, 2026

    Gavi records US$302 million in lower-income vaccine funding

    April 17, 2026

    Spruce-derived compounds show anticoagulant promise

    April 8, 2026

    WHO launches science-backed World Health Day 2026 push

    April 7, 2026
    Editor's Pick

    Escalating Middle East tensions threaten global petroleum delivery

    July 22, 2026

    Global software teams adopt affordable open access AI systems

    July 22, 2026

    UK unemployment holds steady at 4.9 percent amid wage slowdown

    July 22, 2026

    Sardinia beach entry requires digital reservations and access fees

    July 21, 2026

    Russia sets legal framework for large AI models

    July 20, 2026

    Red heat alerts cover 17 Italian cities

    July 20, 2026

    Indonesia B50 biodiesel boosts domestic palm fuel use

    July 20, 2026

    Samsung holds top 10 rank with US$97.4 billion value

    July 20, 2026
    © 2024 Liverpool Daily Post | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.